Renaissance Technologies
UTRS

Renaissance Technologies’s Minerva Surgical, Inc. Common Stock UTRS Stock Holding History

Renaissance Technologies’s Portfolio UTRS Stock Details UTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-991
Closed -$4K – 4382
2023
Q1 		$4K Buy
+991
New +$6.1K ﹤0.01% 3918
2022
Q1 		– Sell
-758
Closed -$78K – 4592
2021
Q4 		$78K Buy
+758
New +$108K ﹤0.01% 3726

Other funds holding UTRS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FRA
Frank Rimerman Advisors Palo Alto, California $1.77B AUM 41.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Renaissance Technologies's UTRS Position: Q2 2023 in Review

Renaissance Technologies sold out of Minerva Surgical, Inc. Common Stock (UTRS) in Q2 2023, closing a stake of 991 shares — an estimated $4K sold.

Renaissance Technologies first reported a position in UTRS in Q4 2021 and held it in 2 quarters. The position peaked at $78K in Q4 2021. 17 funds tracked by Wall St. Rank hold UTRS as of Q2 2023.

  • Renaissance Technologies reported no remaining Minerva Surgical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Renaissance Technologies sold 991 Minerva Surgical, Inc. Common Stock shares in Q2 2023, an estimated $4K.
  • Renaissance Technologies first reported a position in Minerva Surgical, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Renaissance Technologies's Minerva Surgical, Inc. Common Stock position peaked at $78K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Minerva Surgical, Inc. Common Stock as of Q2 2023.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.